« zurück

COVID-19 Path

An artificial intelligence-based first-line defence against COVID-19: digitally screening patient via a chatbot

Details

Programm / Ausschreibung Emergency-Call Coronavirus 2020, Emergency-Call Coronavirus 2020, KLIPHA-Covid_19
Projektpartner Symptoma GmbH
Projektstart 08.04.2020
Projektende 07.04.2021
Status abgeschlossen
Projektlaufzeit 13 Monate

Projektbeschreibung

Our goal is to help hospitals and doctor offices worldwide to efficiently screen their patients for COVID-19 prior to a consultation or planned surgery. This serves as a first-line defense against any disease or potentially emerging epidemics (including COVID-19). We will achieve this goal by building an artificial intelligence (AI) screening all patients in all European languages (and beyond) capitalizing on (1) the first AI-based chatbot assessing each patient’s risk of having contracted the specific virus, (2) a multilingual reporting platform for medical review and (3) triage for flagged cases. We help hospitals to screen COVID-19 risk in patients digitally before the visit and allow for contactless check-ins. Hospitals direct patients to their website to assess their COVID-19 risk via Symptoma’s AI-based chatbot (integrated into their websites). Patients print out the result which includes a QR code, the COVID-19 risk level (high/medium/low) and a timestamp. Preferably, patients save the report on their smartphone via a dedicated app by Symptoma. Medium/High risk patients are triaged to specialists to diagnose and treat COVID-19. Low risk patients follow a different route as defined by the hospital. Outpatients with smartphones follow this procedure prior to their visit or in waiting rooms for fast check-ins. Assessment can be conducted in +36 different languages, whereas doctors see reports in their own preferred language.

Abstract

Our goal is to help hospitals and doctor offices worldwide to efficiently screen their patients for COVID-19 prior to a consultation or planned surgery. This serves as a first-line defense against any disease or potentially emerging epidemics (including COVID-19). We will achieve this goal by building an artificial intelligence (AI) screening all patients in all European languages (and beyond) capitalizing on (1) the first AI-based chatbot assessing each patient’s risk of having contracted the specific virus, (2) a multilingual reporting platform for medical review and (3) triage for flagged cases. www.symptoma.com

Weitere Informationen